JAK2 and acquired polycythemia vera: It has also been suggested that combined JAK2 and TET2 mutations allow for dramatic proliferation over TET2-negative PV subclones, emphasizing the hypothesis that TET2 mutations increase the aggressive nature of JAK2 mutation-positive PV [24].